Indoor Air Filtration for Ischemic Heart Disease
Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
- Age
- 65 – 84
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 112 (estimated)
- Sponsor
- University of Southern California · Other
This trial is looking for older adults with a history of ischemic heart disease. Participants will test how indoor air filtration can help slow down heart-related problems caused by air pollution.
You may be able to join if
- I am between 65 and 84 years old.
- I weigh at least 110 pounds.
- I have not smoked in the past year.
- I have a stable history of ischemic heart disease for 6 months.
- I speak either English or Spanish.
- I live in Los Angeles County.
You may not be able to join if
- I have a history of dementia or Alzheimer's.
- I am currently receiving cancer treatments.
- My home already has HEPA filters.
- I plan to move in the next 2 years.
- I will spend more than 1 month away from my home.
- I have health conditions that prevent data collection.
- My home cannot accommodate air purifiers and monitors.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis double-blind, randomized, crossover trial aims to test the hypothesis that longer-term indoor air filtration intervention can slow atherothrombosis progression by reducing indoor fine particulate matter (PM2.5) exposure in adults with ischemic heart disease history.
Loading trial locations…